Материалов:
1 082 141

Репозиториев:
30

Авторов:
761 409

По вашему запросу найдено документов: 322954

Страница 1 из 32296

Origin of ferromagnetism in ZnO codoped with Ga and Co: Experiment and theory
He Y., Liu E.Z., Tse J.S., Yin S., Jiang J.Z., Sharma P., Ohtsu N., Inoue A., Biswas K., Inada Y., Nomura M.
Derivation of canopy light absorption coefficient from reflectance spectra
Gitelson A., Viña A., Solovchenko A., Arkebauer T., Inoue Y.
of pigments in the plant canopy. It is a useful metric for understanding the spatial and temporal dynamics
Exploratory trial of urethral submucosa injection therapy of deflux for stress urinary incontinence after radical prostatectomy
Fujihara Atsuko, Shiraishi Takumi, Miyashita Masatsugu, Inoue Yuta, Saito Yumiko, Taga Hideto, Naitoh Yasuyuki, Iwami Yayoi, Horiguchi Go, Ito-Ihara Toshiko, Ukimura Osamu
patient quality-of-life (QOL). A simple and less invasive treatment for SUI in these patients is urgently
Large XCH 4 anomaly in summer 2013 over northeast Asia observed by GOSAT
Ishizawa, Misa, Morino, Isamu, Inoue, Makoto, Yoshida, Yukio, Mabuchi, Kazuo, Shirai, Tomoko, Tohjima, Yasunori, Maksyutov, Shamil Sh, Ohyama, Hirofumi, Uchino, Osamu, Kawakami, Shuji, Takizawa, Atsushi, Belikov, Dmitry A.
over 2009–2012, after removing a long-term trend), as being retrieved from the Short-Wavelength Infra
Therapeutic regimen of l-arginine for MELAS: 9-year, prospective, multicenter, clinical research
Koga Y., Povalko N., Inoue E., Nakamura H., Ishii A., Suzuki Y., Yoneda M., Kanda F., Kubota M., Okada H., Fujii K.
Real-world experience with 5-aminolevulinic acid for photodynamic diagnosis of bladder cancer (3rd report): Cost impact of transurethral resection of bladder tumor in Japan
Fukuhara Hideo, Hagiwara Yasuhiro, Oba Koji, Inoue Keiji
without false-positives and 36 patients with false-positives with a follow-up period of at least 200 days
Xanthogranulomatous epididymitis
Matsuoka K., Yano H., Inoue M., Iida S., Hirabayasi Y., Noda S.
A new diagnostic indication device of a biomarker growth differentiation factor 15 for mitochondrial diseases: From laboratory to automated inspection
Koga Y., Povalko N., Inoue E., Ishii A., Fujii K., Fujii T., Murayama K., Mogami Y., Hata I., Ikawa M., Fukami K., Fukumoto Y., Nomura M., Ichikawa K., Yoshida K.
differentiation factor 15 (GDF15) has been reported as a biomarker useful for not only diagnosing MDs, but also
Enzalutamide versus abiraterone as a first-line endocrine therapy for castration-resistant prostate cancer (ENABLE study for PCa): a study protocol for a multicenter randomized phase III trial
Izumi Kouji, Mizokami Atsushi, Namiki Mikio, Inoue Shogo, Tanaka Nobumichi, Yoshio Yuko, Ishibashi Kei, Kamiyama Manabu, Kawai Noriyasu, Enokida Hideki, Shima Takashi, Takahara Shizuko
for CRPC. The present study is a phase III, investigator-initiated, multicenter, head-to-head, randomized
Biomarkers and clinical rating scales for sodium pyruvate therapy in patients with mitochondrial disease
Koga Y., Povalko N., Inoue E., Nashiki K., Tanaka M.
) that are appropriate in preparing the protocol for a future clinical trial of sodium pyruvate (SP) therapy. A 48-week

Страница 1 из 32296

Фасеты

Партнеры

КФУ
ТГУ
Elpub
СФУ
Webpublishers

Индексация

BASE
WorldCat
OpenAIRE
EDS
core